PATENT CLAIM ANALYSIS

Application Number: 16172487
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "186100"]

Abstract:
Described herein are compositions and methods for treating cancer through the combination of tumor antigen-pulsed dendritic cells and Dengue Virus. The combination of the two forms of therapeutic intervention provides enhanced tumor cell reduction compared to either alone. The cancer targeted by compositions and methods described herein may be a solid cancer or blood cancer.

Claim (Index 10):
The method of  claim 1 , wherein the cancer is a solid cancer or a blood cancer.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.38095
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15200751', '15639632', '15799793', '14532371', '13301545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7506558081058972
- 35 USC 102 Novelty (BERT): 0.5635854811376212
- Combined Prediction Score: 0.7319487754090697
- Mean Citation Score: 337.4339300000001
- Max Citation Score: 433.61792
- Similarity Product: 412.0048377957153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test